Connect with us

3 Good Penny Stocks to Watch During the Market Crash

Here are three penny stocks to add to your watchlist now
The post 3 Good Penny Stocks to Watch During the Market Crash appeared first on Penny Stocks…

Published

on

Top Penny Stocks to Watch As the Market Crashes Again

With another major market crash on June 13th, which penny stocks are investors watching right now? Well, it is tough to say as there is so much movement in the stock market right now. But, to understand this, all we have to do is look at why the market is crashing right now. 

[Read More] Penny Stocks to Buy Right Now? 3 to Watch in Mid-June 2022

For starters, we see that the fear of rising interest rates is causing major bearish sentiment. With inflation rising to highs not seen in years, the Fed is working quickly to combat it. So as investors, it is our job to make sure that we take advantage of these moves no matter what direction the market is going. Considering that, let’s take a look at three hot penny stocks to watch right now. 

3 Penny Stocks to Add to Your Watchlist Right Now

  1. Gingko Bioworks Holdings Inc. (NYSE: DNA)
  2. Applied UV Inc. (NASDAQ: AUVI)
  3. Sos Ltd. (NYSE: SOS)

Gingko Bioworks Holdings Inc. (NYSE: DNA) 

While shares of DNA stock fell by around 15% today, we did see a 3.3% rise during after hours. And, in the past five days, shares of DNA stock have fallen by around 30%. Despite this, we are seeing small glimpses of bullish sentiment on occasion which means that DNA could be worth taking a closer look at right now. 

The most recent news from the company came on June 10th when it announced its party-cation in the Goldman Sachs 43rd Annual Global Healthcare Conference. This conference will take place on June 15th 2022 and will be the next time we see what Gingko is up to. Besides this, not much news has come out of the company recently. A few days before this, the company did announce that it is partnering with Novo Nordisk to build expression systems for pharmaceutical products. 

“It’s an honor to work with partners like Novo Nordisk that not only have an incredible range of critically important products, but that also provide us with the opportunity to do meaningful work that could help so many patients. At Ginkgo, we are always on the lookout for projects that will have an outsized impact on people’s lives and well-being.”

The CEO and CoFounder of Gingko Bioworks, Jason Kelly

With this in mind, do you think DNA stock is worth buying or not?

Penny_Stocks_to_Watch_Gingko

Applied UV Inc. (NASDAQ: AUVI) 

Another penny stock that gained during after hours trading on June 13th is AUVI stock. In after hours, shares of AUVI stock managed to shoot up by over 5.5% following a 2.5% drop. The main reason for this comes as shares of the company have seen some major volatility recently. 

So, to understand this better, let’s take a closer look at what it does. Applied UV is a tech penny stock that focuses on acquiring and developing new technologies. These technologies are used in a variety of industries including healthcare, hospitality, and much more. 

[Read More] Penny Stocks To Watch: Why Hillstream BioPharma (HILS) Is Moving Today

And, with its two wholly owned subsidiaries, SteriLumen and Munn Works, the company has a large amount of exposure to many budding industries right now. And with its UVC LED Lumicide platform, it is also showing promise as a player in fighting the pandemic. While it has seen a large number of ups and downs as of late, AUVI stock remains an interesting tech penny stock. So, whether it is worth adding to your list of penny stocks to or not, is up to you. 

Penny_Stocks_to_Watch_Applied UV Inc. (AUVI Stock Chart)

Sos Ltd. (NYSE: SOS) 

SOS is a penny stock that we have discussed numerous times in the past few months. And today, we saw shares gain by around 2.98% during after hours following a 16% drop during the trading day. So, is today’s after hours move a play for the company’s future, or is it just a speculative uptick? To find out, we have to examine Sos Ltd. in greater detail. Recently, we have seen a sizable amount of bullish sentiment with SOS stock. But, in the last day or two, this has shifted with prices of SOS dropping significantly. 

One of the reasons for this comes as SOS has a major amount of exposure to the cryptocurrency industry. And with the price of bitcoin falling drastically in the last few weeks, it makes sense that SOS would see some bearish sentiment as well. The most recent news from the company came on May 10th, when it announced the launch of a hosting business at the Super Computer and Hosting Center in Wisconsin. This will allow it to manage more than 21,000 mining rigs to date. 

“This launch marks the step-by-step implementation of the company’s plan. We will launch more mining rigs as we sign additional contracts with third parties. We will continue to invest in more high level rigs for our own mining use and increase the manpower to support local operations. This will add more jobs and support the local economy.”

The CEO of SOS, Mr. Yandai Wang

Because SOS stock is so volatile, it is impossible to say if shares will continue to move in either direction. With this considered, will it be on your penny stocks watchlist?

Which Penny Stocks Are You Watching Right Now?

Finding penny stocks to buy during such a topsy turvy time in the market can be difficult. But, by understanding what is going on, investors can have a much greater chance of taking advantage.

[Read More] What to Know About Trading Penny Stocks on June 13th

Because there are so many factors at play, investors need to constantly stay on their toes as it relates to daily market moves. With this in mind, which penny stocks are you watching right now?

[reblex id='29520']

The post 3 Good Penny Stocks to Watch During the Market Crash appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Read More

Continue Reading

International

Repeated COVID-19 Vaccination Weakens Immune System: Study

Repeated COVID-19 Vaccination Weakens Immune System: Study

Authored by Zachary Stieber via The Epoch Times (emphasis ours),

Repeated COVID-19…

Published

on

Repeated COVID-19 Vaccination Weakens Immune System: Study

Authored by Zachary Stieber via The Epoch Times (emphasis ours),

Repeated COVID-19 vaccination weakens the immune system, potentially making people susceptible to life-threatening conditions such as cancer, according to a new study.

A man is given a COVID-19 vaccine in Chelsea, Mass., on Feb. 16, 2021. (Joseph Prezioso/AFP via Getty Images)

Multiple doses of the Pfizer or Moderna COVID-19 vaccines lead to higher levels of antibodies called IgG4, which can provide a protective effect. But a growing body of evidence indicates that the “abnormally high levels” of the immunoglobulin subclass actually make the immune system more susceptible to the COVID-19 spike protein in the vaccines, researchers said in the paper.

They pointed to experiments performed on mice that found multiple boosters on top of the initial COVID-19 vaccination “significantly decreased” protection against both the Delta and Omicron virus variants and testing that found a spike in IgG4 levels after repeat Pfizer vaccination, suggesting immune exhaustion.

Studies have detected higher levels of IgG4 in people who died with COVID-19 when compared to those who recovered and linked the levels with another known determinant of COVID-19-related mortality, the researchers also noted.

A review of the literature also showed that vaccines against HIV, malaria, and pertussis also induce the production of IgG4.

“In sum, COVID-19 epidemiological studies cited in our work plus the failure of HIV, Malaria, and Pertussis vaccines constitute irrefutable evidence demonstrating that an increase in IgG4 levels impairs immune responses,” Alberto Rubio Casillas, a researcher with the biology laboratory at the University of Guadalajara in Mexico and one of the authors of the new paper, told The Epoch Times via email.

The paper was published by the journal Vaccines in May.

Pfizer and Moderna officials didn’t respond to requests for comment.

Both companies utilize messenger RNA (mRNA) technology in their vaccines.

Dr. Robert Malone, who helped invent the technology, said the paper illustrates why he’s been warning about the negative effects of repeated vaccination.

“I warned that more jabs can result in what’s called high zone tolerance, of which the switch to IgG4 is one of the mechanisms. And now we have data that clearly demonstrate that’s occurring in the case of this as well as some other vaccines,” Malone, who wasn’t involved with the study, told The Epoch Times.

So it’s basically validating that this rush to administer and re-administer without having solid data to back those decisions was highly counterproductive and appears to have resulted in a cohort of people that are actually more susceptible to the disease.”

Possible Problems

The weakened immune systems brought about by repeated vaccination could lead to serious problems, including cancer, the researchers said.

Read more here...

Tyler Durden Sat, 06/03/2023 - 22:30

Read More

Continue Reading

Spread & Containment

Robert F. Kennedy Jr. Banned By Major Social Media Site, Campaign Pages Blocked

Robert F. Kennedy Jr. Banned By Major Social Media Site, Campaign Pages Blocked

Authored by Jack Phillips via The Epoch Times (emphasis ours),

Twitter…

Published

on

Robert F. Kennedy Jr. Banned By Major Social Media Site, Campaign Pages Blocked

Authored by Jack Phillips via The Epoch Times (emphasis ours),

Twitter owner Elon Musk invited Democrat presidential candidate Robert F. Kennedy Jr. for a discussion on his Twitter Spaces after Kennedy said his campaign was suspended by Meta-owned Instagram.

Interesting… when we use our TeamKennedy email address to set up @instagram accounts we get an automatic 180-day ban. Can anyone guess why that’s happening?” he wrote on Twitter.

An accompanying image shows that Instagram said it “suspended” his “Team Kennedy” account and that there “are 180 days remaining to disagree” with the company’s decision.

Robert F. Kennedy, Jr. attends Keep it Clean to benefit Waterkeeper Alliance in Los Angeles, Calif., on March 1, 2018. (John Sciulli/Getty Images for Waterkeeper Alliance)

In response to his post, Musk wrote: “Would you like to do a Spaces discussion with me next week?” Kennedy agreed, saying he would do it Monday at 2 p.m. ET.

Hours later, Kennedy wrote that Instagram “still hasn’t reinstated my account, which was banned years ago with more than 900k followers.” He argued that “to silence a major political candidate is profoundly undemocratic.”

“Social media is the modern equivalent of the town square,” the candidate, who is the nephew of former President John F. Kennedy, wrote. “How can democracy function if only some candidates have access to it?”

The Epoch Times approached Instagram for comment.

It’s not the first time that either Facebook or Instagram has taken action against Kennedy. In 2021, Instagram banned him from posting claims about vaccine safety and COVID-19.

After he was banned by the platform, Kennedy said that his Instagram posts raised legitimate concerns about vaccines and were backed by research. His account was banned just days after Facebook and Instagram announced they would block the spread of what they described as misinformation about vaccines, including research saying the shots cause autism, are dangerous, or are ineffective.

“This kind of censorship is counterproductive if our objective is a safe and effective vaccine supply,” he said at the time.

Read more here...

Tyler Durden Sat, 06/03/2023 - 20:30

Read More

Continue Reading

International

Study Falsely Linking Hydroxychloroquine To Increased Deaths Frequently Cited Even After Retraction

Study Falsely Linking Hydroxychloroquine To Increased Deaths Frequently Cited Even After Retraction

Authored by Jessie Zhang via Thje Epoch…

Published

on

Study Falsely Linking Hydroxychloroquine To Increased Deaths Frequently Cited Even After Retraction

Authored by Jessie Zhang via Thje Epoch Times (emphasis ours),

An Australian and Swedish investigation has found that among the hundreds of COVID-19 research papers that have been withdrawn, a retracted study linking the drug hydroxychloroquine to increased mortality was the most cited paper.

Hydroxychloroquine sulphate tablets. (Memories Over Mocha/Shutterstock)

With 1,360 citations at the time of data extraction, researchers in the field were still referring to the paper “Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis” long after it was retracted.

Authors of the analysis involving the University of Wollongong, Linköping University, and Western Sydney Local Health District wrote (pdf) that “most researchers who cite retracted research do not identify that the paper is retracted, even when submitting long after the paper has been withdrawn.”

“This has serious implications for the reliability of published research and the academic literature, which need to be addressed,” they said.

Retraction is the final safeguard against academic error and misconduct, and thus a cornerstone of the entire process of knowledge generation.”

Scientists Question Findings

Over 100 medical professionals wrote an open letter, raising ten major issues with the paper.

These included the fact that there was “no ethics review” and “unusually small reported variances in baseline variables, interventions and outcomes,” as well as “no mention of the countries or hospitals that contributed to the data source and no acknowledgments to their contributions.”

A bottle of Hydroxychloroquine at the Medicine Shoppe in Wilkes-Barre, Pa on March 31, 2020. Some politicians and doctors were sparring over whether to use hydroxychloroquine against the new coronavirus, with many scientists saying the evidence is too thin to recommend it yet. (Mark Moran/The Citizens’ Voice via AP)

Other concerns were that the average daily doses of hydroxychloroquine were higher than the FDA-recommended amounts, which would present skewed results.

They also found that the data that was reportedly from Australian patients did not seem to match data from the Australian government.

Eventually, the study led the World Health Organization to temporarily suspend the trial of hydroxychloroquine on COVID-19 patients and to the UK regulatory body, MHRA, requesting the temporary pause of recruitment into all hydroxychloroquine trials in the UK.

France also changed its national recommendation of the drug in COVID-19 treatments and halted all trials.

Currently, a total of 337 research papers on COVID-19 have been retracted, according to Retraction Watch.

Further retractions are expected as the investigation of proceeds.

Tyler Durden Sat, 06/03/2023 - 17:30

Read More

Continue Reading

Trending